Cooperative DNA binding of the bovine papillomavirus type 1 (BPV-1) E2 transcriptional activator (E2-TA) is thought to play a role in the transcriptional synergism of multiple E2-responsive DNA elements (J. Ham, N. Dostatni, J.-M. Gauthier, and M. Yaniv, Trends Biochem. Sci. 16:440-444, 1991). Binding-equilibrium considerations show that such involvement is unlikely, thereby suggesting that the E2-TA cooperative capacity may have evolved to play other, different roles. The role of cooperative interactions in the antagonistic activity of BPV-1-positive and BPV-1-negative E2 regulatory proteins was investigated by an in vitro quantitative gel shift assay. Viral repressor E2-TR, a truncated peptide encompassing the activator DNA-binding domain, possesses a small but measurable cooperative capacity. Furthermore, the minimal E2 DNA-binding domain interacts with the activator in a positive, heterocooperative manner. As a result, the in vitro competition of full-length and truncated E2 peptides appears to be (macroscopically) noncooperative. This heterocooperative effect is probably dominant in latently infected Go-G1 cells, in which repressor E2-TR is 10-to 20-fold more abundant than the activator. The data are discussed considering the possible role of homo-and heterocooperative DNA binding in E2-conditional gene expression.
Interaction of multiple sequence-specific DNA-binding activator molecules with transcriptional promoters and enhancers results in the synergic activation of gene expression (45) . Multimerized DNA-binding sites, in either a homologous or heterologous combination, elicit a transcriptional response that is more than additive with respect to single sites (8, 12, 30-32, 34, 41, 42, 46, 47, 52) . Duplication of a binding site can induce a dramatic stimulation of gene expression; additional sites do not necessarily cooperate in a strong, synergistic fashion (8) . These phenomena are a general feature of the most thoroughly studied activators, such as Gal4 (8, 14) ; Oct-1 (42) and ; the estrogen (34) , glucocorticoid (22, 46, 47, 52) , and progesterone receptors (55) ; the transcriptional enhancer factor 1 (TEF-1) (11); the activating transcription factor (ATF) (32) ; the upstream stimulatory factor (USF) (31) ; and the bovine papillomavirus type 1 (BPV-1) E2 transcriptional activator (E2-TA) (13, 16, 19, 23, 25, 30, 48, 49, 54) .
There is evidence that transcriptional synergism may be caused by the cooperative binding of transcriptional activators to DNA (28, 34, 45, 55) . Other observations contradict this conclusion (4, 8, 32, 43) . Another possible explanation for transcriptional synergism is that multiple activator molecules assembled at DNA regulatory sequences are specifically recognized by an additional factor (8, 32, 45) . These mechanisms are not necessarily mutually exclusive. Finally, a model has been proposed in which the binding of a TATA factor may be dramatically stabilized by "sampling" several activator molecules bound to DNA sequences in a tandem array (45) .
Transcriptional synergism of multimerized, homologous binding sites is generally measured by comparing the expression of a reporter gene in cells transfected with single-site versus multisite templates. Cooperative DNA binding is thought to determine a synergistic activation of gene expression by inducing an additional degree of template saturation by the activator. This hypothesis requires that a fraction of the single-site template be free under the conditions used for the transfection experiments (8) . If the single-site template has already been saturated by the activator, transfection of a multisite template would not elicit any additional level of gene expression. A similar prediction has been verified for yeast activator Gal4 and mammalian factor ATF, which, in an in vitro assay, have proved to synergize independently of cooperative binding (8, 32) . Recently we measured, by a quantitative gel retardation assay, the cooperativity parameter of the BPV-1 homodimer activator E2-TA (2, 15, 19, 40, 51) for two adjacent DNAbinding sites separated by 1.5 helix turns (37) . This parameter was estimated to be 8.5. In vivo, the same DNA fragment is able to enhance the expression of a reporter gene by 50-fold with respect to a single binding site (16) . Such in vitro and in vivo measurements make it possible to evaluate the role of E2 cooperative DNA binding in transcriptional synergy.
How strong must E2 cooperative interactions be to account for the synergic effect observed in vivo? E2-TA binding to a DNA fragment containing one or two adjacent binding sites (a and b) is described in Fig. 1A palindrome ACCGAAAACGGT (16, 37) , the two binding sites are here assumed to have similar affinities (however, as a result of flanking nucleotides, this is not always the case) (29) . Positive cooperativity occurs for K,,, > 1, negative cooperativity occurs for Kay, < 1, and independent binding occurs for Kab = 1 (1). Fractions 4q and 42 are described by the following expressions: = KP/(1 + KP) (1) )2 =(2KP + K2Kai2p2)I(1 + 2KP + K2KaP) (2) where P is the concentration of free protein. An appropriate way to compare the two fractions is by using their ratio, is now presented. The association constant (Ka) of the single-site 41-bp DNA fragment was previously determined to be 5.3 x 10 M-1 (37) . The overall association constant for the two-binding-site DNA fragment [(Ka + Kb)!2] was now determined. The DNA probe was purified, labeled, and quantified as described previously (37) . The full-length E2 peptide used in these experiments is the same one that was used in a previous study, and purification and binding properties were described in that study (37) . Different amounts of E2-TA protein were incubated with a fixed probe concentration, and complexes were resolved by gel shift as previously described (37) . Unlike experiments performed to calculate cooperativity parameters, these experiments were done at low concentrations; hence, E2-TA binding was nonstoichiometric. DNA complexes and free probe were quantified on a Betascope 603 blot analyzer (Betagen, Walthman, Mass.) (3) as previously described (37) (Fig. 2) (48, 50) . In addition to activator E2-TA, BPV-1 encodes two transcriptional repressors, E2-TR and E8/E2. These peptides lack the E2-regulatory domain but retain the ability to interact with target DNA sequences, thereby competing with the E2 activator for specific DNA binding (9, 20, 27) . A possible function for E2-TA cooperative DNA binding could be to antagonize the interaction of E2 repressors with the viral enhancer E2RE1. In fact, unlike activator E2-TA, E2 truncated peptides fail to loop DNA sequences with an E2-responsive motif at each end (23) , suggesting that the E2 repressors may not possess cooperativity capacities comparable to that of the full-length protein. This conclusion is further supported by the observation that an 86-aminoacid peptide (86-E2), encompassing the minimal DNA-binding domain, binds to adjacent sites with a cooperativity parameter of 1.9 (37) .
To verify this hypothesis, the BPV-1 repressor E2-TR was synthesized by infecting Spodoptera frugiperda Sf-9 cells with a recombinant baculovirus (53) . BPV-1 sequences encoding the viral repressor (nucleotides 3098 to 4450) were isolated with BamHI endonuclease from plasmid pYE2-R (38), a gift of E. J. Androphy, Tufts University School of Medicine, Boston, Mass., and inserted in plasmid pBlueBac (Invitrogen, San Diego, Calif.), whose cloning site was replaced by a BglII site. Following Blue-gal-plaque purification (Maxbac, baculovirus expression system, manual version 1.4; Invitrogen), insect cells were infected with a single isolate and the protein was purified to homogeneity by affinity chromatography (data not shown) as previously described for the BPV-1 E2 transcriptional activator (37) .
The binding of the repressor to adjacent binding sites was then investigated, as previously described for E2-TA (37) , by titrating a fixed amount of the two-binding-site DNA fragment with increasing amounts of the protein. As observed for the transcriptional activator, binding of the repressor to the oligonucleotide yielded two principal shifts corresponding to the occupancy of one or two sites (Fig. 3) . A faint band, which may correspond to an E2 repressor degradation product, was also detected. The cooperativity parameter was calculated by the maximum of one-site occupancy, as previously described (37) . The graph in Fig. 3 The maximum of the single-site binding isotherm is 0.37; the cooperativity parameter (2.9) was calculated as previously described (37) . This value represents a macroscopic estimate, since we have made the assumption in our analysis that the two binding sites have equal affinities. If the affinities are not equal, the cooperativity parameter is higher. The same assumption was previously made for E2-TA and 86-E2 proteins (37) .
In vivo, the E2 polypeptides bind to adjacent E2-responsive elements in a competitive manner. To gain a more complete understanding of the role of E2 cooperative DNA binding in viral gene expression, we performed competition experiments with truncated and full-length peptides and the 54-bp two-site probe. Because of their similar electrophoretic mobilities, experiments with the E2 activator and E2-TR repressor yielded little information. At lower acrylamide concentrations or at lower acrylamide/bisacrylamide ratios, the complexes were better resolved; however, dissociation phenomena occurred, preventing a quantitative analysis of the binding isotherms. A quantitative analysis of the competitive binding was indeed possible with 86-E2, whose binding properties have been described previously (37) In one experiment performed by titrating a fixed amount of the oligonucleotide with a mixture of the two proteins (whose ratio was constant), all the expected bands were identified (data not shown). A second experiment was performed by incubating the oligonucleotide with a saturating concentration of 86-E2 in the presence of increasing amounts of the full-length E2 protein (Fig. 4B) . Three principal complexes were detected, corresponding to the doubly bound probe in the three possible combinations (pp, Pp, and PP). Radioactive complexes were quantified, and binding isotherms were determined. As the full-length E2 protein was added to the binding mixture, the pp complex concentration decreased, the Pp complex concentration reached a maximum, and the PP complex concentration increased (Fig. 4C) . the PP complex (fpp = fpp), the ratio of fractionsfpp andfp (fp/fpp) must be described by the following equation, which is independent of the free-protein concentration. fPpIfPP = (KAKbKAb + KaKBKaB)I(KaKbKAKBKabKAB)05 (6) Assuming that both proteins show comparable affinities for binding sites a and b (KA = KB, ka = kb) and interact with the DNA in a noncooperative way (KAB, Kab, KAb, KaB = 1), equation 6 reduces to fppIfpp = (2Kk)/(K2k2)05 = 2 (7) and this implies that atf, = fpp, thefp fraction must be 0.5 and the fp andfP fractilons must be 0.25. These values are very close to the experimental fractions, since at this point fp, was found to be 0.52 and fp (=fpp) was 0.23 ( Fig. 4C) .
Hiowever, because of the cooperative capacity of the two proteins, fraction fpp should be lower than in the case of non-cooperative competition. This suggests that some cooperative interaction (here referred to as heterocooperative interaction) takes place between the large and truncated peptides and that the interplay of cooperative interactions and affinities forces the system to behave as expected for noncooperative binding. These observations suggest that the E2-TA homocooperative capacity plays only a marginal role in the activation of viral enhancer E2RE1 under conditions of competitive binding.
A heterocooperative parameter for the interaction between the E2 full-length and truncated peptides could be determined by substituting the experimental values for cooperativity parameters K,4B (8.5) and Kab (1.9) and for fractionsfpp (=0.52) andfpp (=0.23) in equation 6: (KAKbKAb + KaKBKaB)I(KaKbKAKB)05 = 9.1 (8) Assuming that the two proteins display similar affinities for binding sites a and b (KA = KB; ka = kb), an overall, macroscopic heterocooperativity parameter (KaB + KAb) is calculated from equation 8, which reduces to (KaB + KAb) = 9.1. The average value for the heterocooperative binding of the full-length and truncated E2 polypeptides can thus be determined to be 4.5. Such an average estimate is higher than the cooperativity parameter for both the minimal DNAbinding domain peptide and repressor E2-TR. This suggests that the E2 regulatory domain may (i) interact with the C-terminal domain of an adjacent, truncated molecule or (ii) induce a DNA conformational transition, eventually affecting DNA bending caused by its C-terminal domain (6, 39) , facilitating the binding of an adjacent, truncated peptide. These results show that cooperative DNA binding can be a complex phenomenon. Indeed, binding energies involved in the interaction of macromolecular domains are not additive (21) . In this respect, to consider transcriptional regulators to be modular proteins whose domains are strictly responsible for separate functions could be a useful but sometimes imprecise approximation.
An additional experiment performed by incubating the DNA probe with a saturating concentration of the full-length E2 protein in the presence of increasing amounts of the 86-amino-acid peptide gave similar results, with an overall heterocooperativity parameter (KAb + KaB) of 8.1 (data not shown).
In transformed cells latently infected with BPV-1, repressors E2-TR and E8/E2 are significantly more abundant than are E2 activator molecules (20 (Fig. 5) . Assuming that pseudo-sites are negligible with respect to the bulk of unrelated sequences (36) , the dissociation constant for nonspecific DNA binding, Kd, is given by the following expression (equation 9), originally developed by Lin and Riggs (33) for the Eschenichia coli lac repressor. Kd = 2KsD0.5/(2P -E-2Ks), (9) where Ks is the dissociation constant for the specific DNA binding, DO.5 is the concentration of nonspecific sites required to reduce the fractional saturation of the oligonucleotide to 0.5; and Pt and Et are the absolute protein and specific site concentrations, respectively. p18IE2M, containing one specific E2-binding motif, was very effective in inhibiting the specific binding of both the full-length and the truncated E2 proteins. The other competitor DNAs displayed variable degrees of inhibition. According to equation 9, the nonspecific dissociation constant of the full-length E2 protein was calculated to range from 5 x 10' to 1 x 10-5 M and the E2 repressor Kd was found to range from 2.5 x 10-7 to 1 x 10-5 M (Table 1) 16, 18, and 33 (13) . Those studies suggested that the active form of the E2 activator may consist of two adjacent dimers (a "functional E2 tetramer" [13] ) interacting with some additional factor. The present finding that cooperative binding cannot account for the E2 transcriptional synergy supports this conclusion. However, our study suggests possible roles for E2 cooperative DNA binding. The E2 polypeptides form heterodimers through their carboxy-terminal DNA-binding domain (35, 44) . Experiments performed with truncated E2 peptides competent for dimerization but not for DNA binding suggested that heterodimerization of full-length and truncated E2 proteins is a major mechanism for transcriptional repression (5) . Those studies also suggested that the full-length E2 activator is not competent for trans-activation when present in a heterodimeric form with E2-TR. Repressor E2-TR is significantly more abundant than both E2-TA and E8/E2 in BPV-1 transformed cells at the Go and early G1 phases of the cell cycle (56) . In those cells, E2-TR homodimers must predominate over the E2 heterodimeric forms, and this suggests that E2-conditional gene expression may be regulated essentially by the interplay of E2-TA and E2-TR homodimers under conditions of nonproductive viral infection. The present in vitro analysis could apply to this in vivo situation.
According to the cooperative capacities of E2 proteins, E2-TA homocooperative binding to adjacent sites would be antagonized by heterocooperative interactions. Under conditions of competitive binding, a fraction of the templates would have one site occupied by E2-TA and the other occupied by E2-TR. Nonadjacent sites could display a similar behavior, since heterocooperative interactions may enable distantly bound E2-TA and E2-TR molecules to loop intertwining DNA sequences as described for E2-TA homodimers (23) . In contrast, the low E2-TR homocooperative capacity would not favor the occupancy of adjacent sites by E2-TR molecules.
There is no absolute stereoalignment constraint for E2 transcriptional synergy, and synergic activation is observed when adjacent E2-binding sites are on the opposite faces of the DNA double helix (13, 48) . It has been suggested that this could reflect the ability of the E2 "hinge" region to wrap around the DNA, enabling the transactivating domains of two adjacent E2-TA molecules to interact in the proper way (15, 48) . The flexible E2 hinge region could similarly facilitate the heterocooperative interaction of the trans-activating domain of an activator molecule with the DNA-binding domain of a truncated, adjacent peptide. Since E2-TR homocooperativity probably reflects the interactions of E2 DNA-binding domains, occupancy of adjacent sites by E2-TR would be further discouraged by site misalignment.
These observations suggest that heterocooperative interactions could determine a primed state with half of a functional E2 tetramer already in place. Such a "committed" state could be relevant for the transcriptional regulation of BPV-1 promoters during the dynamic changes of E2 protein concentrations through the cell cycle (56) .
Truncated and full-length E2 proteins are present in comparable amounts in BPV-1-transformed cells during late G1, S, M, and G2 phases or in giant cells permissive for viral DNA amplification induced by growth arrest of transformed cultures (7, 56) . It is conceivable that, under these conditions, binding and cooperative properties of the E2 heterodimeric molecules would predominate over homodimeric cooperative capacities. These properties should therefore be fully elucidated for a complete understanding of BPV-1 biology.
The present study has been conducted in vitro with purified proteins and naked DNA. An (10, 57) . E2 proteins could be involved in a similar mechanism along the BPV-1 noncoding region, and homoand heterocooperative interactions might be a part of the energetic balance involved in nucleosome displacement (or alteration) in the viral life cycle.
